Peptidoglycan (PGN) is a macrophage activator from Gram-positive bacteria. PGN activates cells of hemopoietic origin through CD14 since: (i) PGN-unresponsive CD14-negative cells become PGNresponsive after transfection with CD14 and expression of membrane CD14; (ii) PGN binds to CD14 with high affinity; and (iii) anti-CD14 mAbs inhibit both binding of PGN to CD14 and activation of CD14-positive cells by PGN. However, there are several differences in the function of CD14 as PGN and LPS receptor: (i) the kinetics of binding are different; (ii) the affinity of binding in the absence of LPS-binding protein (LBP) is higher for PGN than LPS; (iii) LBP does not increase the affinity of binding of PGN to CD14 and does not enhance cell activation by PGN (in contrast to LPS); (iv) the regions of CD14 needed for binding and activation are partially similar and partially different for PGN and LPS; (v) sCD14:PGN complexes, in contrast to sCD14:LPS complexes, do not activate CD14-negative cells; (vi) PGN, in contrast to LPS, does not activate CHO cells expressing mCD14; and (vii) PGN and LPS induce differential activation of MAP kinases, but activate similar transcription factors (NF-κB, ATF1/CREB, and AP-1).
References
1.
Schleifer KH , Kandler O.Peptidoglycan types in the bacterial cell walls and their taxonomic implications. Bacteriol Rev1975; 36: 407—477.
2.
Rietschel ET , Kirikae T., Schade FU et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J1994; 8: 217—225.
3.
Heymer B., Seidl PH, Schleifer KHImmunochemistry and biological activity of peptidoglycan. In: Stewart-Tull DES, Davis M , eds. Immunology of the Bacterial Cell Envelope . New York: Wiley, 1985; 11—46.
Johannsen L.Biological properties of bacterial peptidoglycan . APMIS1993; 101: 337—344.
6.
De Kimpe SJ, Kengatharan M., Thiemermann C., Vane JRThe cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci USA1995; 92: 10359—10363.
7.
Beutler B., Cerami A.Tumor necrosis, cachexia, shock, and inflammation: a common mediator . Annu Rev Biochem1988; 57: 505—518.
8.
Beutler B., Grau GETumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med1993; 21: S423—S435.
9.
Durum SK, Schmidt JA, Oppenheim JJInterleukin 1: an immunological perspective. Annu Rev Immunol1985; 3: 263—287.
10.
Van Snick J.Interleukin-6: an overview. Annu Rev Immunol1990; 8: 253—278.
11.
Vacheron F., Guenounou M., Nauciel C.Induction of interleukin 1 secretion by adjuvant-active peptidoglycans . Infect Immun1983; 42: 1049—1053.
12.
Mathison JC, Tobias PS, Wolfson E., Ulevitch RJPlasma lipopolysaccharide (LPS)-binding protein: a key component in macrophage recognition of Gram-negative LPS. J Immunol1992; 149: 200—206.
13.
Timmerman CP , Mattsson E., Martinez-Martinez L. et al. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infect Immun1993; 61: 4167—4172.
14.
Weidemann B. , Brade H., Rietschel ET et al. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun1994; 62: 4709—4715.
15.
Gupta D., Jin Y., Dziarski R.Peptidoglycan induces transcription and secretion of TNF-α and activation of Lyn, extracellular signal-regulated kinase, and Rsk signal transduction proteins in mouse macrophages. J Immunol1995 ; 155: 2620—2630.
16.
Gupta D., Kirkland TN, Viriyakosol S., Dziarski R.CD14 is a cell-activating receptor for bacterial peptidoglycan. J Biol Chem1996; 271: 23310—23316.
17.
Jin Y., Gupta D., Dziarski R.Endothelial and epithelial cells do not respond to complexes of peptidoglycan with soluble CD14, but are activated indirectly by peptidoglycan-induced tumor necrosis factor-α and interleukin-1 from monocytes. J Infect Dis1998; 177: 1629—1638.
18.
Weidemann B. , Schletter J., Dziarski R. et al. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect Immun1997; 65: 858—864.
19.
Dziarski R. , Tapping RI, Tobias P.Binding of bacterial peptidoglycan to CD14 . J Biol Chem1998; 273: 8680—8690.
20.
Juan Ts-C , Hailman E., Kelley MJ et al. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J Biol Chem1995; 270: 5219—5224.
21.
Stelter F., Bernheiden M., Menzel R. et al. Mutation of amino acids 39—44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. Eur J Biochem1997; 243: 100—109.
22.
Frey EA, Miller DS, Jahr TG et al. Soluble CD14 participates in the response of cells to lipopolysaccharide . J Exp Med1992; 176: 1665—1671.
23.
Pugin J., Schurer-Maly C-C., Leturq D., Moriarty A., Ulevitch RJ, Tobias PSLipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA1993; 90: 2744—2748.
24.
Haziot A., Rong G-W., Silver J., Goyert SMRecombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide . J Immunol1993; 151: 1500—1507.
25.
Pugin J., Ulevitch RJ, Tobias PSA critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J Exp Med1993; 178: 2193—2200.
26.
Pugin J., Ulevitch RJ, Tobias PSTumor necrosis factor-α and interleukin-1β mediate human endothelial cell activation in blood at low endotoxin concentrations. J Inflamm1995; 45: 49—55.
27.
Ulevitch RJ , Tobias PSReceptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol1995 ; 13: 437—457.
28.
Yang R-B., Mark MR, Gray A. et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature1998; 395: 284—288.
29.
Kirschning CJ, Wesche H, Ayres TM, Rothe M. Human Toll-like receptor 2 confers responsiveness to bacterial LPS. J Exp Med1998; 188: 2091—2097.
30.
Tapping RI, Tobias PSCellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein. J Biol Chem1997; 272: 23157—23164.
31.
Kitchens RJ , Munford RSCD14-dependent internalization of bacterial lipopolysaccharide (LPS) is strongly influenced by LPS aggregation but not by cellular responses to LPS. J Immunol1998 ; 160: 1920—1928.
32.
Gegner JA, Ulevitch RJ, Tobias PSLipopolysaccharide (LPS) signal transduction and clearance: dual roles for LPS binding protein and membrane CD14. J Immunol1995; 270: 5320—5325.
33.
Haziot A., Ferrero E., Kontgen F. et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity1996; 4: 407—414.
34.
Haziot A., Lin XY, Zhang F., Goyert SMThe induction of acute phase proteins by lipopolysaccharide uses a novel pathway that is CD14-independent. J Immunol1998; 160: 2570—2572.
35.
Stefanova I. , Horejsi V., Ansotegui IJ, Knapp W., Stockinger H.GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science1991; 254: 1016—1019.
36.
Beaty CD, Franklin TL, Uehara Y., Wilson CBLipopolysaccharide-induced cytokine production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction. Eur J Immunol1994; 24: 1278—1284.
37.
Henricson BE , Carboni JM, Burkhardt AL, Vogel SNLPS and taxol activate Lyn kinase autophosphorylation in LPSn, but not in LPSd, macrophages. Mol Med1995; 1: 428—435.
38.
Weinstein SL , Sanghera JS, Lemke K., DeFranco AL, Pelech SLBacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages . J Biol Chem1992; 267: 14955—14962.
39.
Han J., Lee J-D., Bibbs L., Ulevitch RJA MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells . Science1994; 265: 808—811.
40.
Liu MK, Herrera-Velit P., Brownsey RW, Reiner NECD14dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide . J Exp Med1994; 153: 2642—2652.
41.
Raingeaud J. , Gupta S., Rogers JS et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem1995 ; 270: 7420—7426.
42.
Hambelton J. , Weinstein SL, Lem L., DeFranco ALActivation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages . Proc Natl Acad Sci USA1996; 93: 2774—2778.
43.
Dziarski R. , Jin Y., Gupta D.Differential activation of extracellular signal-regulated kinase (ERK) 1, ERK2, p38, and c-Jun NH2-terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan. J Infect Dis1996; 174: 777—785.
44.
Sweet MJ, Hume DAEndotoxin signal transduction in macrophages, J Leukoc Biol1996; 60: 8—26.
